Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)

Table 3 Tumor response

	Overall	H101	Control	P value
Alpha-fetoprotein(ng/ml) reduce				0.448
≥ 20 %	77	41	36
< 20 %	98	46	52
Lipiodol retention				0.002
None	20	7	13
Partial	132	61	71
Complete	23	19	4

CR complete response, PR partial response, SD stable disease, PD progressive disease

ISSN: 1471-2407